Clinical Trial Update: Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating different dosing strategies of colistin for infections caused by multidrug-resistant Gram-negative bacteria; Phase 2/Phase 3, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Gram-negative Bacterial Infections

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: Mansoura University | Conditions: Critical Ill Patients, Multi Drug Resistant | Phase 2, Phase 3 | Status: RECRUITING